
Tirzepatide Has Better Metabolics. So Why Doesn't It Win?
Your patient has type 2 diabetes, established cardiovascular disease, and has been on tirzepatide for two years. Their A1c is down, their weight is down, and their triglycerides are better than they've been in a decade.






